ALFUZOSINE VIATRIS L.P. 10 mg, extended-release tablet 30 tablets, CIP 3400937045230
Active ingredients: Alfuzosin hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release tablet30 tablets, CIP 3400937045230orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ALFUZOSINE VIATRIS L.P. 10 mg, comprimé à libération prolongée
- Pharmaceutical form
- comprimé à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC de 30 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 30%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Troubles liés à une hypertrophie bénigne de la prostate<br>- Troubles urinaires chez les patients atteints de sclérose en plaques (prise en charge sur facture en dehors du périmètre des biens et services remboursables) ; JOURNAL OFFICIEL ; 06/04/11
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 18 May 2006
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60513032CIP73704523CIP133400937045230Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'ALFUZOSINEcomprimé | 10 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.